. Fbw7, is perturbed in many human malignancies and is an established tumor suppressor (8) (9) (10) (11) . Mouse Fbw7 exists in three different isoforms: α, β, and γ.
The α isoform is expressed ubiquitously, whereas the β and γ isoforms are restrictedly expressed in the brain, heart, testis, and skeletal muscle (12) .
Intriguing characteristics of Fbw7α have recently been described by Ericsson et al. who
demonstrated that this cell growth regulator also regulated the degradation of the nuclear forms of the sterol regulatory element binding protein (SREBP) family (13, 14) . Without a proteasome inhibitor such as calpain inhibitor I in cell cultures, nuclear SREBPs are rapidly degraded by the ubiquitin-proteasome pathway after cleavage. Recently, Fbw7 was reported to be the key factor for this degradation of SREBPs in cultured cells (14) . SREBP-1a is phosphorylated at several sites depending on the cell cycle and then degraded by the ubiquitin-proteasome system. During mitosis, nuclear SREBP-1a is stabilized, and it activates lipid synthesis to supply membrane lipids (25).
Thus, Fbw7 controls the degradation of SREBPs in cultured cells in relation to the cell cycle and growth. However, its physiological roles in vivo are yet to be determined. In the present study, the effects of Fbw7α modification on SREBPs and lipid metabolism in the liver were investigated.
Experimental procedures
Materials -Antibodies to phosphorylated c-Jun promoter (SREBP1c-Tg) were generated as described previously (26). In addition, SREBP-1 knockout mice (SREBP1-KO) (6-8-week-old)
were generated as described previously (27).
KLF5 flox mice, in which the second exon was flanked by two lox sites, were also prepared and established (Ema M, manuscript in preparation). analyses were performed using the ABI 7300 PCR system (Applied Biosystems). Quantification of fat-specific protein 27 (Fsp27) was performed using a Taqman gene expression assay (Applied Biosystems), while quantification of other genes was performed using the SYBR-Green Dye (Nippon Gene, Tokyo, Japan). The relative abundance of each transcript was calculated using a standard curve of cycle thresholds for serial dilutions of a cDNA sample and then normalized to cyclophilin levels (31). The expression levels of cyclophilin used as an internal control in each experiment were not affected by procedures such as siRNA transfection. Primer sequences are described in Supplementary Table S1 .
Measurement of metabolic parameters -We measured the plasma levels of glucose, insulin, non-esterified fatty acid (NEFA), TG, total cholesterol (TC), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) as well as the levels of TG and TC in the liver, as described previously (32) .
Expression plasmids -The expression plasmid for the human nuclear form of SREBP-1c has been described previously (33) . Expression plasmids encoding mouse Fbw7α and KLF5 were generated by PCR amplification, followed by the insertion of cDNAs into pcDNA3.1(+) (Promega ( Figure 1A ). This hepatic Fbw7 knockdown caused fatty liver and a slight, but significant, enlargement of the liver ( Figures 1B and 1C ).
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These mice exhibited no significant changes in food intake, white adipose tissue weight, or body weight compared to animals infected with adenovirus producing LacZ siRNA (LacZi) as a control ( Figure 1D and data not shown). Of the plasma metabolic parameters, TG, glucose, and insulin levels were reduced significantly by infection with Fbw7i (Table 1 ). These data indicated that fatty liver was not likely to be associated with overnutrition or obesity.
Hepatosteatosis was confirmed by liver histology ( Figure 1E ) with a marked increase in the liver content of TG ( Figure 1F ), but not TC ( Figure   1G ). These data indicated that fatty liver induced by (Figures 10B and 10C ). These findings demonstrated that KLF5 mediates the Fbw7-PPARγ2 pathway.
To reveal the pathophysiological situation where
Fbw7α regulates PPARγ2, we tested the effect of PPARα activation on pathological fatty liver.
Obese mice such as db/db or ob/ob mice with leptin deficiency, exhibited severe hepatosteatosis with marked induction of PPARγ2 (42, 45) .
Fibrates that have a PPARα agonist action ameliorate fatty liver associated with a reduction in PPARγ2. The mechanism for this action has yet to be determined (46) . In db/db mice, the level of nuclear Fbw7 protein was low, while KLF5
protein level was high compared with the control C57BL/6 mice. This suggests that Fbw7 contributes to PPARγ2 regulation (data not shown). Furthermore, ob/ob mice were treated with fenofibrate, and this system was examined ( Figure 11) . Interestingly, the PPARα agonist caused strong induction of the nuclear Fbw7 protein, accompanied by a reduction in the KLF5 protein ( Figure 11A ). This explains the suppression of PPARγ2 and TG content by
PPARα activation ( Figures 11B and 11C ).
Discussion
Previous in vitro studies have suggested that Fbw7 is involved in the degradation of the nuclear SREBP protein (14) . The present study was (Table 1) .
Furthermore, our findings indicated that KLF5
was a direct target of Fbw7 in vivo and in vitro.
Based on the data from KLF5-deleted hepatocytes, KLF5 could at least partially explain PPARγ2 up-regulation by suppression of hepatic Fbw7α.
As shown in Figure 10 , the induction of PPARγ2 Fbw7 is thought to be a cell growth regulator.
The present study demonstrated an association of 
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Figure Legends 
LacZi or Fbw7i. The quantities of mRNA were determined by real-time PCR and normalized by the cyclophilin level in each cDNA sample. mRNA levels were shown as the expression ratio relative to the LacZi control group. n = 4 or 5 per group in all panels. Statistical analysis was performed using unpaired Student's t-test; ** p < 0.01 (versus respective LacZi control group). 
expression ratio relative to both the LacZi-and Ad-GFP-infected control groups. All experiments were performed using four sets of primary hepatocytes for each group. Statistical analyses were performed using two-way ANOVA followed by Tukey's procedure; * p < 0.05 (versus LacZi of each group) and # p < 0.05 (versus LacZi or Fbw7i of Ad-GFP group). 
